Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Acquisitions & Divestments (2016 - 2024)

Historic Change in Acquisitions & Divestments for Myriad Genetics (MYGN) over the last 16 years, with Q3 2024 value amounting to $5.0 million.

  • Myriad Genetics' Change in Acquisitions & Divestments fell 6666.67% to $5.0 million in Q3 2024 from the same period last year, while for Jun 2025 it was $5.0 million, marking a year-over-year decrease of 7560.98%. This contributed to the annual value of $9.0 million for FY2024, which is 9144.49% down from last year.
  • Myriad Genetics' Change in Acquisitions & Divestments amounted to $5.0 million in Q3 2024, which was down 6666.67% from $2.5 million recorded in Q2 2024.
  • Over the past 5 years, Myriad Genetics' Change in Acquisitions & Divestments peaked at $58.1 million during Q1 2023, and registered a low of $1.5 million during Q4 2023.
  • In the last 5 years, Myriad Genetics' Change in Acquisitions & Divestments had a median value of $18.6 million in 2020 and averaged $21.7 million.
  • In the last 5 years, Myriad Genetics' Change in Acquisitions & Divestments skyrocketed by 31890.24% in 2020 and then tumbled by 9741.82% in 2024.
  • Quarter analysis of 5 years shows Myriad Genetics' Change in Acquisitions & Divestments stood at $35.9 million in 2020, then crashed by 32.31% to $24.3 million in 2021, then surged by 67.08% to $40.6 million in 2022, then crashed by 96.31% to $1.5 million in 2023, then surged by 233.33% to $5.0 million in 2024.
  • Its last three reported values are $5.0 million in Q3 2024, $2.5 million for Q2 2024, and $1.5 million during Q1 2024.